Literature DB >> 12527886

Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein.

Caroline Demeret1, Alejandro Garcia-Carranca, Françoise Thierry.   

Abstract

Cervical carcinomas are most frequently associated with human papillomaviruses (HPV), whose E6 and E7 oncogenes products induce cellular immortalization. The papillomavirus E2 protein is a transcription factor, which represses the expression of the viral oncogenes, and activates viral DNA replication during the vegetative viral cycle. This protein is specifically inactivated in HPV18-associated carcinoma cells, suggesting that E2 functions prevent carcinogenic progression. Indeed, ectopic expression of E2 in cervical carcinoma cells strongly inhibits cell proliferation. Here we show that above a threshold level of expression, the E2 protein induces apoptosis, independently of other viral functions. The amino-terminal domain is responsible for this apoptotic activity, but surprisingly with no involvement of its transcriptional functions. The death pathway triggered by E2 relies on activation of the initiator caspase 8, specific of the extrinsic pathway of apoptosis. E2 itself is cleaved by caspases during cell death, providing an example of an apoptotic inducer that is itself a target for caspase processing. The autonomous proapoptotic activity of HPV18 E2 described here may counteract the proliferative functions of viral oncogenes, and renders the inactivation of E2 crucial for carcinogenic progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527886     DOI: 10.1038/sj.onc.1206108

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein.

Authors:  Jasmin Fertey; José Hurst; Elke Straub; Astrid Schenker; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

2.  E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death.

Authors:  Joanna L Parish; Anna Kowalczyk; Hsin-Tien Chen; Geraldine E Roeder; Richard Sessions; Malcolm Buckle; Kevin Gaston
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.

Authors:  Noor Gammoh; Helena Sterlinko Grm; Paola Massimi; Lawrence Banks
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity.

Authors:  Xin Wang; Mei Qi; Xiuping Yu; Yan Yuan; Weiming Zhao
Journal:  J Gen Virol       Date:  2012-03-21       Impact factor: 3.891

5.  Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence.

Authors:  Kimberly Johung; Edward C Goodwin; Daniel DiMaio
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

6.  Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.

Authors:  Sophie Bellanger; Chye Ling Tan; Yue Zhen Xue; Sébastien Teissier; Françoise Thierry
Journal:  Am J Cancer Res       Date:  2011-01-24       Impact factor: 6.166

7.  Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic pattern.

Authors:  Kerstin Leykauf; Kirsten Kabsch; Nikolaus Gassler; Lutz Gissmann; Angel Alonso; Johannes Schenkel
Journal:  Transgenic Res       Date:  2007-08-16       Impact factor: 2.788

8.  The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes.

Authors:  Monika Oldak; Hans Smola; Monique Aumailley; Francisco Rivero; Herbert Pfister; Sigrun Smola-Hess
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  A new E6/P63 pathway, together with a strong E7/E2F mitotic pathway, modulates the transcriptome in cervical cancer cells.

Authors:  Sébastien Teissier; Youcef Ben Khalifa; Marcella Mori; Patricia Pautier; Christian Desaintes; Françoise Thierry
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

10.  Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses.

Authors:  Ruprecht Kuner; Markus Vogt; Holger Sultmann; Andreas Buness; Susanne Dymalla; Julia Bulkescher; Mark Fellmann; Karin Butz; Annemarie Poustka; Felix Hoppe-Seyler
Journal:  J Mol Med (Berl)       Date:  2007-06-23       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.